Human MxA protein protects mice lacking a functional alpha/beta interferon system against La Crosse virus and other lethal viral infections

Journal of Virology

Volumn 73, Issue 8, 1999, Pages 6984-6991

  Hefti, Hans Peter ^a   Frese, Michael ^b   Landis, Heinrich ^a   Di Paolo, Claudio ^a   Aguzzi, Adriano ^a   Haller, Otto ^b   Pavlovic, Jovan ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CYTOPLASM PROTEIN; INTERFERON RECEPTOR;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; IMMUNOHISTOCHEMISTRY; LA CROSSE VIRUS; MOUSE; NONHUMAN; ORTHOMYXOVIRUS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; SEMLIKI FOREST ALPHAVIRUS; VIRUS INFECTION; VIRUS REPLICATION;

EID: 0032775260     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.8.6984-6991.1999     Document Type: Article

References (44)

1. Aebi, M., J. Fäh, N. Hurt, C. E. Samuel, D. Thomis, L. Bazzigher, J. Pavlovic, O. Haller, and P. Staweheli. 1989. cDNA structures and regulation of two interferon-induced human Mx proteins. Mol. Cell. Biol. 9:5062-5072.
2. Albanese, M., C. Bruno-Smiraglia, G. Di Cuonzo, A. Lavagnino, and S. Srihongse. 1972. Isolation of Thogoto virus from Rhipicephalus bursa ticks in western Sicily. Acta Virol. 16:267.
3. Arnheiter, H., M. Frese, R. Kamadur, E. Meier, and O. Haller. 1995. Mx transgenic mice - animal models of health. Curr. Top. Microbiol. Immunol. 206:119-147.
4. Calisher, C. H. 1994. Medically important arboviruses of the United States and Canada. Clin. Microbiol. Rev. 7:89-116.
5. Centers for Disease Control and Prevention. 1998. Arboviral infections of the central nervous system - United States, 1996-1997, Morbid. Mortal. Weekly Rep. 47:517-522.
6. Fiette, L., C. Aubert, U. Müller, S. Huang, M. Aguet, M. Brahic, and J. F. Bureau. 1995. Theiler's virus infection of 129Sv mice that lack the interferon alpha/beta or interferon gamma receptors. J. Exp. Med. 181:2069-2076.
7. Filipe, A. R., M. C. Peleteiro, T. M. Monath, and E. H. Calisher. 1986. Pathological lesions in mice infected with Thogoto virus, a tick-borne orthomyxovirus. Acta Virol. 30:337-340.
8. Fleming, P. 1977. Age-dependent and strain-related differences of virulence of Semliki Forest virus in mice. J. Gen. Virol. 37:93-105.
9. Frese, M., G. Kochs, H. Feldmann, C. Hertkorn, and O. Haller. 1996. Inhibition of bunyaviruses, phleboviruses, and hantaviruses by human MxA protein. J. Virol. 70:915-923.
10. Frese, M., G. Kochs, U. Meier-Dieter, J. Siebler, and O. Haller. 1995. Human MxA protein inhibits tick-borne Thogoto virus but not Dhori virus. J. Virol. 69:3904-3909.
11. Frese, M., M. Weeber, F. Weber, V. Speth, and O. Haller. 1997. Mx1 sensitivity: Batken virus is an orthomyxovirus closely related to Dhori virus. J. Gen. Virol. 78:2453-2458.
12. Gautier, C., M. Mehtali, and R. Lathe. 1989. A ubiquitous mammalian expression vector, pHMG, based on a housekeeping gene promoter. Nucleic Acids Res. 17:8389.
13. Gonzalez-Scarano, F., and N. Nathanson. 1996. Bunyaviridae, p. 1473-1504. In B. N. Fields (ed.), Virology. Lippincott-Raven Publishers, Philadelphia, Pa.
14. Gresser, I., M. G. Tovey, M. T. Bandu, C. Maury, and D. Broury-Boye. 1976. Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. I. Rapid evolution of encephalomyocarditis virus infection. J. Exp. Med. 144:1305-1315.
15. Gresser, I., M. G. Tovey, C. Maury, and M. T. Bandu. 1976. Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. II. Studies with herpes simplex, Moloney sarcoma, vesicular stomatitis, Newcastle disease, and influenza viruses. J. Exp. Med. 144:1316-1326.
16. Griot, C., F. Gonzalez-Scarano, and N. Nathanson. 1994. Molecular determinants of the virulence and infectivity of California serogroup bunyaviruses. Annu. Rev. Microbiol. 47:117-138.
17. Haller, O., H. Arnheiter, I. Gresser, and J. Lindenmann. 1979. Genetically determined, interferon-dependent resistance to influenza virus in mice. J. Exp. Med. 149:601-612.
18. Haller, O., M. Frese, and G. Kochs. 1998. Mx proteins: mediators of innate resistance to RNA viruses. Rev. Sci. Tech. Off. Int. Epizoot. 17:220-230.
19. Haller, O., M. Frese, D. Rost, P. A. Nuttall, and G. Kochs. 1995. Tick-borne Thogoto virus infection in mice is inhibited by the orthomyxovirus resistance gene product Mx1. J. Virol. 69:2596-2601.
20. Hefti, H. P., and J. Pavlovic. 1998. Unpublished results.
21. Horisberger, M. A., and H. K. Hochkeppel. 1987. IFN-alpha induced human 78 kD protein: purification and homologies with the mouse Mx protein, production of monoclonal antibodies, and potentiation effect of IFN-gamma. J. Interferon Res. 7:331-343.
22. Janssen, R., F. Gonzalez-Scarano, and N. Nathanson. 1984. Mechanisms of bunyavirus virulence. Comparative pathogenesis of a virulent strain of La Crosse virus and an avirulent strain of Tahyna virus. Lab. Investig. 50:447-455.
23. Johnson, K. P., and R. T. Johnson. 1968. California encephalitis. II. Studies of experimental infection in the mouse. J. Neuropathol. Exp. Neurol. 27: 390-400.
24. Kalfayan, B. 1983. Pathology of La Crosse virus infections in humans, p. 179-186. In C. H. Calisher and W. H. Thompson (ed.), California serogroup viruses. A. R. Liss, New York, N.Y.
25. Kanerva, M., K. Melen, A. Vaheri, and I. Julkunen. 1996. Inhibition of puumala and tula hantaviruses in Vero cells by MxA protein. Virology 224:55-62.
26. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
27. Landis, H., A. Simon-Jödicke, A. Klöti, C. Di Paolo, J. J. Schnorr, S. Schneider-Schaulies, H. P. Hefti, and J. Pavlovic. 1998. Human MxA protein confers resistance to Semliki Forest virus and inhibits the amplification of a Semliki Forest virus-based replicon in the absence of viral structural proteins. J. Virol. 72:1516-1522.
28. Müller, U., U. Steinhoff, L. F. L. Reis, S. Hernmi, J. Pavlovic, R. M. Zinkernagel, and M. Aguet. 1994. Functional role of type I and type II interferons in antiviral defense. Science 264:1918-1921.
29. Pavlovic, J., H. A. Arzet, H. P. Hefti, M. Frese, D. Rost, B. Ernst, E. Kolb, P. Staeheli, and O. Haller. 1995. Enhanced virus resistance of transgenic mice expressing the human MxA protein. J. Virol. 69:4506-4510.
30. Pavlovic, J., O. Haller, and P. Staeheli. 1992. Human and mouse Mx proteins inhibit different steps of the influenza virus multiplication cycle. J. Virol. 64:2564-2569.
31. Pavlovic, J., T. Zürcher, O. Haller, and P. Staeheli. 1990. Resistance to influenza virus and vesicular stomatitis virus conferred by expression of human MxA protein. J. Virol. 64:3370-3375.
32. Powers, A. M., K. I. Kamrud, K. E. Olson, S. Higgs, J. O. Carlson, and B. J. Beaty. 1996. Molecularly engineered resistance to California serogroup virus replication in mosquito cells and mosquitoes. Proc. Natl. Acad. Sci. USA 93:4187-4191.
33. Roers, A., H. K. Hochkeppel, M. A. Horisberger, A. Hovanessian, and O. Haller. 1994. MxA gene expression after live virus vaccination: a sensitive marker for endogenous type I Interferon. J. Infect. Dis. 169:807-813.
34. Schindler, C., and J. E. Darnell, Jr. 1995. Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Annu. Rev. Biochem. 64:621-651.
35. Schneider-Schaulies, S., J. Schneider-Schaulies, A. Schuster, M. Bayer, J. Pavlovic, and V. ter Meulen. 1994. Cell type-specific MxA-mediated inhibition of measles virus transcription in human brain cells. J. Virol. 68:6910-6917.
36. Schnorr, J. J., S. Schneider-Schaulies, A. Simon-Jödicke, J. Pavlovic, M. A. Horisberger, and V. ter Meulen. 1993. MxA-dependent inhibition of measles virus glycoprotein synthesis in a stably transfected human monocytic cell line. J. Virol. 67:4760-4768.
37. Sen, G. C., and R. M. Ransohoff. 1993. Interferon-induced antiviral actions and their regulation. Adv. Virus Res. 42:57-102.
38. Staeheli, P. 1990. Interferon-induced proteins and the antiviral state. Adv. Virus Res. 38:147-200.
39. Staeheli, P., R. Grob, E. Meier, J. G. Sutcliffe, and O. Haller. 1988. Influenza virus-susceptible mice carry Mx genes with a large deletion or a nonsense mutation. Mol. Cell. Biol. 8:4518-4523.
40. Staeheli, P., and O. Haller. 1985. Interferon-induced human protein with homology to protein Mx of influenza virus-resistant mice. Mol. Cell. Biol. 5:2150-2153.
41. Staeheli, P., F. Pitossi, and J. Pavlovic. 1993. Mx proteins: GTPases with antiviral activity. Trends Cell Biol. 3:268-272.
42. Staeheli, P., and J. G. Sutcliffe. 1988. Identification of a second interferon-regulated murine Mx gene. Mol. Cell. Biol. 8:4524-4528.
43. Thompson, W. H., B. Kalfayan, and R. O. Anslow. 1965. Isolation of California encephalitis group virus from a fatal human illness. Am. J. Epidemiol. 81:245-253.
44. Zhao, H., B. P. De, and A. K. Banerjee. 1996. Inhibition of human parainfluenza virus-3 replication by interferon and human MxA. Virology 220:330-338.